Literature DB >> 7672483

Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin.

A A Young1, B Gedulin, W Vine, A Percy, T J Rink.   

Abstract

Gastric emptying was measured in normal and insulin-treated spontaneously diabetic BB rats using the retention of an acaloric methylcellulose gel containing phenol red delivered by gavage. Dye content in stomachs removed after killing 20 min later was determined spectroscopically, and was compared to that in rats killed immediately after gavage to assess emptying. Diabetic rats had a markedly greater gastric emptying (90.3 +/- 1.7% passed) compared to normal Harlan Sprague Dawley rats (49.1 +/- 4.7% passed; p < 0.001) and non-diabetic BB rats (61.1 +/- 9.2% passed; p < 0.001). The pancreatic beta-cell peptide, amylin, which is deficient in insulin-dependent diabetes mellitus, dose-dependently inhibited gastric emptying in both normal and diabetic rats. The ED50 of the response in normal rats measured by phenol red and novel [3-3H]glucose gavage techniques was approximately 0.4 microgram. This dose was estimated to increase plasma amylin concentration by a mean of approximately 20 pmol/l to concentrations within the range observed in vivo. It is proposed that amylin could participate in the physiological control of nutrient entry into the duodenum and that the accelerated gastric emptying seen in BB rats could be related to their lack of amylin secretion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672483     DOI: 10.1007/bf00401833

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  21 in total

1.  Hyperglycaemia stimulates pyloric motility in normal subjects.

Authors:  R Fraser; M Horowitz; J Dent
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

2.  Depletion of islet amyloid polypeptide in the spontaneously diabetic (BB) Wistar rat.

Authors:  D Bretherton-Watt; M A Ghatei; S Legon; H Jamal; K Suda; S R Bloom
Journal:  J Mol Endocrinol       Date:  1991-02       Impact factor: 5.098

3.  Regulation of the gastric emptying of glucose.

Authors:  W Brener; T R Hendrix; P R McHugh
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

4.  The role of insulin in the intestinal absorption of glucose in the rat.

Authors:  J M Argilés; A Zegrí; J Arbós; C García; F J López-Soriano
Journal:  Int J Biochem       Date:  1992-04

5.  Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity.

Authors:  T R Pieber; J Roitelman; Y Lee; K L Luskey; D T Stein
Journal:  Am J Physiol       Date:  1994-07

Review 6.  Disordered gastric motor function in diabetes mellitus.

Authors:  M Horowitz; R Fraser
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

7.  CGRP 8-37[correction of 8-27] blocks the inhibition of gastric emptying induced by intravenous injection of alpha-CGRP in rats.

Authors:  V Plourde; S St-Pierre; A Fournier; Y Taché
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

8.  Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.

Authors:  R A Liddle; R J Rushakoff; E T Morita; L Beccaria; J D Carter; I D Goldfine
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

9.  Intracisternal injection of pancreatic polypeptide stimulates gastric emptying in rats.

Authors:  T Okumura; T N Pappas; I L Taylor
Journal:  Neurosci Lett       Date:  1994-08-29       Impact factor: 3.046

10.  Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.

Authors:  K Inoue; A Hisatomi; F Umeda; H Nawata
Journal:  Horm Metab Res       Date:  1991-09       Impact factor: 2.936

View more
  22 in total

Review 1.  Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions.

Authors:  Nicholas P Hays; Pietro R Galassetti; Robert H Coker
Journal:  Pharmacol Ther       Date:  2008-03-02       Impact factor: 12.310

Review 2.  Amylin-mediated control of glycemia, energy balance, and cognition.

Authors:  Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2016-02-27

3.  Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.

Authors:  O G Kolterman; S Schwartz; C Corder; B Levy; L Klaff; J Peterson; A Gottlieb
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats.

Authors:  M Feigh; K V Andreassen; A V Neutzsky-Wulff; S T Petersen; C Hansen; A C Bay-Jensen; J E Henriksen; H Beck-Nielsen; C Christiansen; K Henriksen; M A Karsdal
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

5.  A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference.

Authors:  Sofie Gydesen; Sara Toftegaard Hjuler; Zenia Freving; Kim Vietz Andreassen; Nina Sonne; Lars I Hellgren; Morten Asser Karsdal; Kim Henriksen
Journal:  Br J Pharmacol       Date:  2017-02-15       Impact factor: 8.739

Review 6.  Control of energy homeostasis by amylin.

Authors:  Thomas A Lutz
Journal:  Cell Mol Life Sci       Date:  2011-12-23       Impact factor: 9.261

7.  Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations.

Authors:  R G Thompson; L Pearson; O G Kolterman
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

8.  Palatable food access impacts expression of amylin receptor components in the mesocorticolimbic system.

Authors:  Houda Nashawi; Tyler J Gustafson; Elizabeth G Mietlicki-Baase
Journal:  Exp Physiol       Date:  2020-05-13       Impact factor: 2.969

9.  Influence of New Modified Biliopancreatic Diversion on Blood Glucose and Lipids in GK rats.

Authors:  Shangeng Weng; Bin Zhang; Changguo Xu; Su Feng; Hongxing He
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

Review 10.  Noninsulin glucose-lowering agents for the treatment of patients on dialysis.

Authors:  Colleen Flynn; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2013-01-29       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.